entinostat has been researched along with Arachnoidal Cerebellar Sarcoma, Circumscribed in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Entinostat treatment changed the expression of genes involved in 22 pathways, including downregulation of DNA damage response." | 1.91 | Class I HDAC inhibition reduces DNA damage repair capacity of MYC-amplified medulloblastoma cells. ( Ecker, J; Hielscher, T; Jamaladdin, N; Milde, T; Oehme, I; Peterziel, H; Ridinger, J; Valinciute, G; van Tilburg, CM; Vollmer, J; Witt, O, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Valinciute, G | 2 |
| Ecker, J | 2 |
| Selt, F | 1 |
| Hielscher, T | 2 |
| Sigaud, R | 1 |
| Ridinger, J | 2 |
| Thatikonda, V | 1 |
| Gatzweiler, C | 1 |
| Robinson, S | 1 |
| Talbot, J | 1 |
| Bernardi, F | 1 |
| Picard, D | 1 |
| Blattner-Johnson, M | 1 |
| Schmid, S | 1 |
| Jones, DT | 1 |
| van Tilburg, CM | 2 |
| Capper, D | 1 |
| Kool, M | 1 |
| Remke, M | 1 |
| Oehme, I | 2 |
| Pfister, SM | 1 |
| Roussel, MF | 1 |
| Ayrault, O | 1 |
| Witt, O | 2 |
| Milde, T | 2 |
| Vollmer, J | 1 |
| Jamaladdin, N | 1 |
| Peterziel, H | 1 |
| Aguilera, DG | 1 |
| Das, CM | 1 |
| Sinnappah-Kang, ND | 1 |
| Joyce, C | 1 |
| Taylor, PH | 1 |
| Wen, S | 1 |
| Hasselblatt, M | 1 |
| Paulus, W | 1 |
| Fuller, G | 1 |
| Wolff, JE | 1 |
| Gopalakrishnan, V | 1 |
| Häcker, S | 1 |
| Dittrich, A | 1 |
| Mohr, A | 1 |
| Schweitzer, T | 1 |
| Rutkowski, S | 1 |
| Krauss, J | 1 |
| Debatin, KM | 1 |
| Fulda, S | 1 |
| Nesterenko, I | 1 |
| Wanningen, S | 1 |
| Bagci-Onder, T | 1 |
| Anderegg, M | 1 |
| Shah, K | 1 |
5 other studies available for entinostat and Arachnoidal Cerebellar Sarcoma, Circumscribed
| Article | Year |
|---|---|
Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cells.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cerebellar Neoplasms; Histone Deacetylase Inhibito | 2023 |
Class I HDAC inhibition reduces DNA damage repair capacity of MYC-amplified medulloblastoma cells.
Topics: Cell Line, Tumor; Cerebellar Neoplasms; Child; DNA Damage; Histone Deacetylase Inhibitors; Humans; M | 2023 |
Reactivation of death receptor 4 (DR4) expression sensitizes medulloblastoma cell lines to TRAIL.
Topics: Apoptosis; Benzamides; Blotting, Western; Caspase 8; Cell Line, Tumor; Cerebellar Neoplasms; Enzyme | 2009 |
Histone deacetylase inhibitors cooperate with IFN-gamma to restore caspase-8 expression and overcome TRAIL resistance in cancers with silencing of caspase-8.
Topics: Benzamides; Caspase 8; Cell Line, Tumor; Cell Survival; Cerebellar Neoplasms; Drug Combinations; Dru | 2009 |
Evaluating the effect of therapeutic stem cells on TRAIL resistant and sensitive medulloblastomas.
Topics: Animals; Apoptosis; Benzamides; Cerebellar Neoplasms; Drug Carriers; Drug Resistance, Neoplasm; Gene | 2012 |